V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007950 | 300004024 | 1.55 | 59.9 | Curative (C) | 2017-07-02 | 2017-08-05 | VEPEMB | 02 | N | 300008116 | CISPLATIN + FLUOROURACIL |
| 300007951 | 300006631 | 1.6 | 57.55 | Neo-adjuvant (N) | 2015-05-28 | 2015-05-28 | Cisplatin | 02 | N | 300008148 | CETUXIMAB |
| 300007952 | 300004047 | 1.55 | 0 | Palliative (P) | 2019-05-01 | 2019-05-24 | CAPECITABINE + RT | 02 | N | 300008405 | BEVACIZUMAB |
| 300007953 | 300006646 | 1.83 | 80.3 | null | 2019-01-17 | 2019-01-21 | Carboplatin AUC 2 - 5 | 02 | N | 300008410 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300007955 | 300004063 | null | 56.8 | null | null | 2016-10-04 | Carboplatin AUC 2 - 5 | 02 | N | 300008549 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007956 | 300004065 | 0 | 60.4 | Neo-adjuvant (N) | 2017-03-03 | 2017-03-04 | DE-ESCALATE TRIAL | 02 | null | 300008554 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007957 | 300004073 | 1.59 | 34 | Curative (C) | 2016-01-01 | 2016-01-05 | Cisplatin | N | Y | 300008620 | CETUXIMAB |
| 300007958 | 300004083 | 1.64 | 74.5 | Palliative (P) | 2019-08-11 | 2019-09-01 | Cisplatin + Etoposide po&iv 3 day | N | N | 300008712 | CARBOPLATIN |
| 300007959 | 300004085 | 1.65 | 59.8 | Palliative (P) | 2015-12-17 | 2015-12-30 | Capecitabine | N | N | 300008724 | PACLITAXEL |
| 300007960 | 300004087 | 1.77 | 74 | Palliative (P) | 2014-08-04 | 2015-09-15 | Gemcitabine + Capecitabine | N | N | 300008772 | ERIBULIN |
| 300007961 | 300004096 | null | 88.3 | null | 2015-10-12 | 2015-10-12 | Cetuximab + Radiotherapy Maint | N | N | 300008892 | CAPECITABINE |
| 300007962 | 300004107 | 1.81 | null | null | 2018-07-23 | 2018-07-25 | Docetaxel | null | null | 300008979 | CAPECITABINE + CISPLATIN |
| 300007963 | 300004110 | 1.78 | 58.6 | Palliative (P) | null | 2018-08-11 | Folfirinox | N | N | 300009014 | OXALIPLATIN + MDG |
| 300007964 | 300004111 | null | 52.8 | Palliative (P) | null | 2017-12-01 | Carboplatin AUC 2 - 5 | N | N | 300009033 | CISPLATIN |
| 300007965 | 300004115 | 1.65 | 91 | Palliative (P) | 2013-07-28 | 2013-10-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 300009057 | BORTEZOMIB |
| 300007966 | 300004117 | 1.76 | null | Curative (C) | 2015-07-05 | 2015-07-19 | Cetuximab + Radiotherapy Maint | N | Y | 300009058 | CARBOPLATIN |
| 300007967 | 300004125 | 1.58 | 55.5 | Curative (C) | 2015-11-15 | 2015-11-29 | Trial Unspecified | 2 | Y | 300009123 | CARBOPLATIN |
| 300007968 | 300004130 | 1.7 | 74.25 | Palliative (P) | 2015-07-15 | 2015-07-15 | PEMBROLIZUMAB | null | null | 300009147 | CARBOPLATIN |
| 300007969 | 300006707 | 1.67 | 73.4 | Disease modification (D) | 2014-01-11 | 2014-01-22 | DE-ESCALATE TRIAL | N | null | 300009289 | CETUXIMAB + RT |
| 300007970 | 300004149 | 1.78 | 87.25 | Palliative (P) | 2018-03-28 | 2018-04-04 | Carboplatin AUC 2 - 5 | 02 | N | 300009313 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 300007971 | 300004163 | 1.84 | 83.4 | null | 2014-11-20 | 2014-11-26 | CARBOPLATIN + RT | N | Y | 300013798 | CARBOPLATIN |
| 300007973 | 300004177 | 1.65 | null | null | 2013-04-26 | 2013-07-19 | CAP + RT | null | Y | 300014044 | CETUXIMAB + RT |
| 300007974 | 300004181 | 1.82 | 81 | Palliative (P) | 2017-06-23 | 2017-08-28 | GemCarbo Days 1+8 | N | N | 300014146 | DOCETAXEL |
| 300007975 | 300004185 | 1.59 | 75.8 | Palliative (P) | 2017-08-16 | 2018-01-24 | Dacarbazine | 2 | N | 300014230 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007976 | 300004188 | 1.65 | 72.4 | Adjuvant (A) | 2014-04-24 | 2015-03-27 | CETUXIMAB + RT | 02 | Y | 300014265 | CETUXIMAB + RT |
| 300007977 | 300004192 | 1.58 | 57 | Palliative (P) | 2016-09-20 | 2016-09-28 | Cisplatin 7 day | null | N | 300014343 | CISPLATIN |
| 300007978 | 300004194 | 1.68 | 74.1 | Palliative (P) | 2014-02-10 | 2014-03-03 | Cisplatin 7 day | N | N | 300014360 | CAPECITABINE + GEMCITABINE |
| 300007979 | 300004195 | 1.63 | 55.7 | Curative (C) | 2017-03-09 | 2017-03-15 | Gemcitabine + Capecitabine | 02 | N | 300014366 | CAPECITABINE + GEMCITABINE |
| 300007980 | 300004207 | 1.58 | 69.85 | Palliative (P) | null | 2016-06-16 | Carboplatin AUC 6 - 10 | Y | null | 300014526 | VAI |
| 300007981 | 300004208 | 1.79 | 76.8 | Palliative (P) | 2015-04-03 | 2015-04-19 | Trial Unspecified | null | null | 300014577 | CETUXIMAB |
| 300007982 | 300004213 | null | 72.7 | Palliative (P) | 2017-08-21 | 2017-09-12 | VAI (Ifos 3g/m2) | 02 | null | 300014618 | CARBOPLATIN |
| 300007983 | 300004215 | 1.81 | 76.1 | Curative (C) | 2014-01-19 | 2015-01-27 | CARBOPLATIN + RT | N | Y | 300014663 | ACTICCA-1 TRIAL |
| 300007984 | 300004218 | null | null | Adjuvant (A) | 2016-11-15 | 2017-03-04 | Trial Unspecified | null | null | 300014670 | PACLITAXEL |
| 300007985 | 300004220 | 1.52 | 88.4 | Palliative (P) | 2017-07-29 | 2017-08-13 | CAPECITABINE + OXALIPLATIN | 2 | N | 300014692 | OXALIPLATIN + MDG |
| 300007987 | 300004233 | 1.73 | 58.75 | Palliative (P) | 2017-11-20 | 2017-11-26 | Irinotecan + Modified De Gramont | N | N | 300014859 | IRINOTECAN + MDG |
| 300007988 | 300004238 | null | 67.3 | Palliative (P) | 2014-10-07 | 2014-10-26 | KESTREL Trial | 02 | N | 300014892 | CISPLATIN + FLUOROURACIL |
| 300007989 | 300004244 | null | 57.4 | Palliative (P) | 2014-08-02 | 2014-09-01 | CARBOPLATIN + RT | null | Y | 300014927 | CAP + RT |
| 300007990 | 300004251 | null | 69 | Palliative (P) | 2016-03-21 | 2016-06-26 | Ipilimumab | N | null | 300014948 | OXALIPLATIN + MDG |
| 300007991 | 300004257 | null | 71 | Palliative (P) | 2016-10-26 | 2016-11-26 | EOX | N | N | 300014985 | CARBOPLATIN |
| 300007992 | 300004264 | 1.79 | 120.9 | Palliative (P) | 2014-12-10 | 2014-12-16 | Carboplatin AUC 2 - 5 | 2 | N | 300015041 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007993 | 300004270 | 1.73 | 70 | Palliative (P) | 2016-10-05 | 2016-10-05 | Folfirinox | 02 | null | 300015077 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007994 | 300004284 | 1.64 | null | null | 2013-09-17 | 2013-11-29 | Cetuximab 7 day (>Cycle 2) | 02 | null | 300015142 | TRIAL |
| 300007995 | 300004288 | 1.72 | null | Palliative (P) | 2014-11-25 | 2014-11-25 | Bevacizumab | N | N | 300015157 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007996 | 300004296 | 1.91 | 82.5 | Palliative (P) | 2017-07-09 | 2018-03-07 | Irinotecan + Modified De Gramont | N | N | 300015203 | GEMCARBO |
| 300007997 | 300004306 | 1.71 | null | Curative (C) | 2015-04-18 | 2015-04-19 | CETUXIMAB + RT | N | Y | 300015251 | CARBOPLATIN + RT |
| 300007998 | 300004308 | 1.78 | 94.7 | Palliative (P) | 2015-06-30 | 2016-08-14 | VAC | N | N | 300015255 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007999 | 300004314 | 1.64 | 61.9 | Palliative (P) | 2017-09-22 | 2017-10-04 | Carboplatin AUC 2 - 5 | 02 | N | 300015288 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300008001 | 300004330 | 1.69 | 79 | Palliative (P) | 2018-01-07 | 2018-02-14 | Carboplatin + Paclitaxel (weekly) | 02 | N | 300015419 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300008003 | 300004337 | 1.65 | null | Palliative (P) | 2018-09-03 | 2018-09-04 | OXALIPLATIN | N | null | 300015484 | CARBO + FLUOROURACIL |
| 300008004 | 300004338 | 1.65 | null | Palliative (P) | null | 2014-02-17 | Cisplatin+Doxorubicin+Etoposide 28d | Y | N | 300015490 | CARBO + FLUOROURACIL |